Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
12.54
+0.15 (1.21%)
At close: Feb 20, 2026, 4:00 PM EST
12.43
-0.11 (-0.91%)
After-hours: Feb 20, 2026, 5:06 PM EST
Erasca Employees
Erasca had 103 employees as of December 31, 2024. The number of employees decreased by 23 or -18.25% compared to the previous year.
Employees
103
Change (1Y)
-23
Growth (1Y)
-18.25%
Revenue / Employee
n/a
Profits / Employee
-$1,239,670
Market Cap
3.88B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Corcept Therapeutics | 500 |
| Arcutis Biotherapeutics | 342 |
| Alumis | 223 |
| Arcellx | 163 |
| Centessa Pharmaceuticals | 114 |
| NewAmsterdam Pharma Company | 77 |
ERAS News
- 17 days ago - Erasca to Present at Upcoming Conferences in February - GlobeNewsWire
- 27 days ago - Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? - Benzinga
- 4 weeks ago - Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 4 weeks ago - Erasca Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Erasca Announces Proposed Public Offering of $150 Million of Common Stock - GlobeNewsWire
- 5 weeks ago - Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones - GlobeNewsWire
- 6 weeks ago - What's Going With Cancer Biotech Erasca Stock On Thursday? - Benzinga
- 6 weeks ago - Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire